Physician profile
Kenneth D Lyons
NPI 1669528741
$2,588.60
in general payments reported to CMS, 2019-2025
16 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $576 · 2022: $1,093 · 2023: $797 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $919.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $661.67 | 2021-2025 | |
| Alkermes, INC. | $396.64 | 2022-2023 | Aristada, Lybalvi, Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $350.58 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $190.96 | 2021-2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $188.23 | 2021-2023 | Rexulti |
| Corium, LLC | $145.66 | 2021-2023 | Azstarys |
| Supernus Pharmaceuticals, INC. | $132.22 | 2021-2025 | Qelbree, Qelbree |
| Lundbeck LLC | $108.43 | 2022-2023 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $92.95 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $85.09 | 2022-2023 | Jornay Pm |
| Tris Pharma INC | $70.13 | 2021-2023 | Dyanavel Xr |
| Neurocrine Biosciences, INC. | $68.65 | 2022-2023 | Ingrezza |
| Eisai INC. | $37.93 | 2021 | |
| Almatica Pharma LLC | $26.85 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.73 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $14.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.